Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

YB-0158

Copy Product Info
😃Good
Catalog No. T38519Cas No. 1144043-83-3
Alias YB-0158, Wnt pathway inhibitor 2

YB-0158 (Wnt pathway inhibitor 2) is a potent peptidomimetic compound that targets colorectal cancer stem cells (CSCs) by disrupting the interaction between Sam68 and Src proteins. As a reverse-turn agent, it induces apoptosis in CRC cells and exhibits strong anti-cancer activity.

YB-0158

YB-0158

Copy Product Info
😃Good
Catalog No. T38519Alias YB-0158, Wnt pathway inhibitor 2Cas No. 1144043-83-3
YB-0158 (Wnt pathway inhibitor 2) is a potent peptidomimetic compound that targets colorectal cancer stem cells (CSCs) by disrupting the interaction between Sam68 and Src proteins. As a reverse-turn agent, it induces apoptosis in CRC cells and exhibits strong anti-cancer activity.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$697InquiryInquiry
10 mg$1,120InquiryInquiry
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
YB-0158 (Wnt pathway inhibitor 2) is a potent peptidomimetic compound that targets colorectal cancer stem cells (CSCs) by disrupting the interaction between Sam68 and Src proteins. As a reverse-turn agent, it induces apoptosis in CRC cells and exhibits strong anti-cancer activity.
Targets&IC50
Wnt:6.2 μM (IC50)
In vitro
YB-0158, at concentrations of 0.2 μM and 0.5 μM over a 48-hour period, significantly enhances apoptosis in CRC cells, as evidenced by activated Caspase-3/7 detection assays[1]. Additionally, a 0.3 μM concentration of YB-0158 markedly reduces CBP recruitment at the LGR5 and MYC promoter regions of Wnt/beta-Catenin target genes in HT29 cells, compared to a DMSO control[1].
In vivo
YB-0158 exhibits an effective concentration (EC 50) of 1.64 μM in MC38 cells cultured in vitro. In vivo experiments utilizing C57BL/6 mice with MC38 cell-derived tumors demonstrate that YB-0158 administered intraperitoneally (IP) at a dose of 100 mg/kg does not significantly alter primary tumor size compared to saline-treated controls[2].
SynonymsYB-0158, Wnt pathway inhibitor 2
Chemical Properties
Molecular Weight703.59
FormulaC32H32N7Na2O7P
Cas No.1144043-83-3
Smiles[H][C@]12CN(C([C@@H](N1C(CN(N2C(NCc3ccccc3)=O)CC=C)=O)Cc4ccc(OP([O-])([O-])=O)cc4)=O)Cc(ccc5)c6c5cn[nH]6.[Na+].[Na+]
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy YB-0158 | purchase YB-0158 | YB-0158 cost | order YB-0158 | YB-0158 chemical structure | YB-0158 in vivo | YB-0158 in vitro | YB-0158 formula | YB-0158 molecular weight